| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VRTX | Common Stock | Award | $0 | +1.17K | +28.91% | $0.00 | 5.21K | May 1, 2023 | Direct | F1 |
| transaction | VRTX | Common Stock | Sale | -$21.4K | -62 | -1.19% | $345.93 | 5.15K | May 2, 2023 | Direct | F2, F3, F4 |
| transaction | VRTX | Common Stock | Sale | -$59.6K | -172 | -3.34% | $346.69 | 4.97K | May 2, 2023 | Direct | F2, F3, F5 |
| transaction | VRTX | Common Stock | Sale | -$41.8K | -120 | -2.41% | $348.16 | 4.85K | May 2, 2023 | Direct | F2, F3, F6 |
| transaction | VRTX | Common Stock | Sale | -$57K | -163 | -3.36% | $349.82 | 4.69K | May 2, 2023 | Direct | F2, F3, F7 |
| transaction | VRTX | Common Stock | Sale | -$22.1K | -63 | -1.34% | $351.20 | 4.63K | May 2, 2023 | Direct | F2, F3, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| F2 | Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022. |
| F3 | Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| F4 | Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12). |
| F5 | Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03). |
| F6 | Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64). |
| F7 | Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08). |
| F8 | Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48). |